Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

31.47
Delayed Data
As of 3:59pm ET
 -0.30 / -0.94%
Today’s Change
28.25
Today|||52-Week Range
37.39
-3.11%
Year-to-Date
Here's the Price Where Fallen Angel Bristol-Myers Becomes an Attractive Takeover Targ...
2:24pm / TheStreet.com - Paid Partner Content
May's industrial strategy to back 'new, active role' for government
Jan 22 / FT.com - Paid Partner Content
Can Q4 Earnings Revitalize Healthcare ETFs?
11:40am / Zacks.com - Paid Partner Content
BioCorRx Receives New Funding for Opioid Drug
Jan 22 / GuruFocus News - Paid Partner Content
5 Stupendously Expensive Cancer Drugs
10:08am / MotleyFool.com - Paid Partner Content
Better Buy: Merck & Co. Inc. vs. Pfizer
Jan 22 / MotleyFool.com - Paid Partner Content
M&A-Hungry Nestle Looking at Baby Food Maker Mead Johnson
9:58am / TheStreet.com - Paid Partner Content
How Will Pfizer Inc. Fare Under President Trump?
Jan 21 / MotleyFool.com - Paid Partner Content
10 Questions That Need to Be Asked Ahead of Johnson & Johnson's Q4 Report
8:40am / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Wo...
Jan 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.77
Today’s open31.68
Day’s range31.44 - 31.82
Volume22,882,708
Average volume (3 months)24,946,982
Market cap$192.8B
Dividend yield4.07%
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.99%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio31.5
Price/Sales4.13
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.71-1.14%
NVSNovartis-0.52-0.74%
SNYSanofi-0.21-0.52%
ABBVAbbVie-0.18-0.29%
Data as of 3:59pm ET, 01/23/2017

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs